Business Daily Media

The Times

.

CD47 Monoclonal Antibody (AK117) Completed Phase I Dose Escalation Trial and Obtained Approval to Initiate Clinical Trial in Combination with Azacitidine for Treatment of Acute Myeloid Leukemia

  • Written by: PR Newswire

HONG KONG, July 13, 2021 /PRNewswire/ -- Akeso, Inc. is pleased to announce that, CD47 monoclonal antibody (AK117), a second-generation novel drug for immuno-oncology therapy independently developed by the Company, has completed phase I dose escalation trial in Australia. AK117 resulted in no dose-limiting toxicity (DLT) and no anemia of clinical...

More Articles …

  1. LOUIS XIII Introduces the Ultra-Rare Red Decanter N°XIII to the World's Most Exclusive Nightclubs
  2. Ribbon Launches Ribbon Connect in Australia and New Zealand for Microsoft Teams Voice Calling
  3. Guidepoint welcomes its newest global office in Sydney, Australia
  4. Hinch Distillery wins gold at International Wine and Spirit Competition 2021
  5. DroneShield (ASX:DRO) Releases Record Results
  6. The Untold Story Releases a Documentary on Prof. Ye Jiaying and Her Life of Poetry
  7. Debate is hotting up in the fledgling period pants industry as leading brands call for regulation to protect consumers from unsubstantiated performance claims
  8. YuppTV launches the top premier streaming platform SonyLIV across International Markets
  9. Thai Cabinet approves amendment to ASEAN pact, Boosting cross-border employment, training, and capacity-building in MICE
  10. OMD Sees Campaign Results Skyrocket by Using IAS Automated Tag with Google

Australian businesses lean into global strategic partnerships (GCCs) for next wave of outsourcing

The Australian corporate landscape is undergoing a fundamental transformation in how it sources talent and innovation. While businesses have traditi...

The New Pressure Gap Crushing Small Businesses

Starting any business and making it prosper is a major undertaking. Part of the challenge is managing the uncertainty, but the financial pressures o...

Click Frenzy returns with a free EOFY sale event for retailers this month

New owners Gabby and Hezi Leibovich bring back Australia’s leading ecommerce sales event with Australia Post as Major Sponsor   Click Frenzy is ...

The 95 Per Cent Failure Rate Is Not An AI Problem

Most Australian SMEs I speak with are already having a go at AI. Some are running formal pilots, others have a team member quietly experimenting o...

New AR tech helping to solve field service skills crisis

AI-enabled augmented reality (AR) smart glasses are emerging as a new practical solution to fill a shortage of field service technicians maintaini...

For Midsize Companies, Global Payroll Systems Matter More to Business-Security Than You Think

When a midsize company expands across borders, its payroll operation becomes exponentially more complex. These organisations typically face a new ...